DK0812206T3 - Fremgangsmåde til stimulering af en immunrespons - Google Patents

Fremgangsmåde til stimulering af en immunrespons

Info

Publication number
DK0812206T3
DK0812206T3 DK96909555T DK96909555T DK0812206T3 DK 0812206 T3 DK0812206 T3 DK 0812206T3 DK 96909555 T DK96909555 T DK 96909555T DK 96909555 T DK96909555 T DK 96909555T DK 0812206 T3 DK0812206 T3 DK 0812206T3
Authority
DK
Denmark
Prior art keywords
immune response
stimulating
individuals
pathogenic
ligand
Prior art date
Application number
DK96909555T
Other languages
English (en)
Inventor
Charles R Maliszewski
Mark Alderson
Kim A Campbell
Mary K Kennedy
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DK0812206T3 publication Critical patent/DK0812206T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
DK96909555T 1995-03-01 1996-02-29 Fremgangsmåde til stimulering af en immunrespons DK0812206T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39623095A 1995-03-01 1995-03-01
PCT/US1996/002839 WO1996026735A1 (en) 1995-03-01 1996-02-29 Method for stimulating an immune response

Publications (1)

Publication Number Publication Date
DK0812206T3 true DK0812206T3 (da) 2002-09-09

Family

ID=23566398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96909555T DK0812206T3 (da) 1995-03-01 1996-02-29 Fremgangsmåde til stimulering af en immunrespons

Country Status (15)

Country Link
EP (1) EP0812206B1 (da)
JP (1) JP3657271B2 (da)
KR (1) KR19980702490A (da)
AT (1) ATE220331T1 (da)
AU (1) AU699291B2 (da)
CA (1) CA2213798C (da)
DE (1) DE69622259T2 (da)
DK (1) DK0812206T3 (da)
ES (1) ES2179187T3 (da)
FI (1) FI973484L (da)
MX (1) MX9706588A (da)
NO (1) NO973875L (da)
NZ (1) NZ305083A (da)
PT (1) PT812206E (da)
WO (1) WO1996026735A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022008A1 (en) * 1997-10-27 1999-05-06 Sumitomo Electric Industries, Ltd. Inducer for production of antigen-specific antibody, expression vector containing gene therefor, and method of inducing production of antigen-specific antibody
CA2313805A1 (en) * 1997-12-19 1999-07-01 Immunex Corporation Method for reducing susceptibility to hiv infection
ES2330017T3 (es) * 1998-05-23 2009-12-03 Leiden University Medical Center Ligandos de cd40 y peptidos de ctl para tratar tumores.
ATE412427T1 (de) 2000-02-02 2008-11-15 Us Health Cd40-ligand als adjuvant für respiratorisches syncytialvirus-impfstoff
PT2066339E (pt) 2006-09-18 2014-10-31 Texas A & M Univ Sys Composições e métodos de potenciar respostas imunes
JP2011502165A (ja) 2007-10-30 2011-01-20 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー 鞭毛細菌に対する免疫応答を強化する組成物および方法
DK2214701T3 (da) 2007-11-01 2016-12-12 Univ Arkansas Sammensætninger og fremgangsmåder til forbedring af immunreaktioner på eimeria
US8956618B2 (en) 2010-01-21 2015-02-17 The Texas A&M University System Vaccine vectors and methods of enhancing immune responses
NZ604412A (en) 2010-06-09 2015-01-30 Univ Arkansas Vaccine and methods to reduce campylobacter infection
CN113461819B (zh) 2011-04-29 2024-01-02 埃派斯进有限公司 抗-cd40抗体及其使用方法
AU2013337903B2 (en) 2012-10-30 2018-08-16 Apexigen, Inc. Anti-CD40 antibodies and methods of use
HUE047484T2 (hu) 2013-02-14 2020-04-28 Univ Arkansas Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
CA2906079C (en) 2013-03-15 2022-08-23 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
IL274572B2 (en) 2015-07-16 2024-01-01 Biolinerx Ltd Compositions and methods for treating cancer
US12297266B2 (en) 2016-04-18 2025-05-13 Celldex Therapeutics, Inc. Agonistic antibodies that bind human CD40 and uses thereof
KR20190015712A (ko) 2016-05-03 2019-02-14 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661360B2 (en) * 1991-10-25 1995-07-20 Immunex Corporation Novel cytokine
AU5098493A (en) * 1992-08-21 1994-03-15 Schering Corporation Cd40 ligand, anti cd40 antibodies, and soluble cd40
ES2211884T3 (es) * 1993-10-01 2004-07-16 Immunex Corporation Anticuerpos contra el cd40.

Also Published As

Publication number Publication date
CA2213798A1 (en) 1996-09-06
MX9706588A (es) 1997-11-29
FI973484A7 (fi) 1997-10-24
ATE220331T1 (de) 2002-07-15
DE69622259D1 (de) 2002-08-14
FI973484L (fi) 1997-10-24
EP0812206A1 (en) 1997-12-17
JP3657271B2 (ja) 2005-06-08
AU5301196A (en) 1996-09-18
NZ305083A (en) 1999-06-29
PT812206E (pt) 2002-11-29
NO973875L (no) 1997-10-31
NO973875D0 (no) 1997-08-22
WO1996026735A1 (en) 1996-09-06
JPH11506418A (ja) 1999-06-08
CA2213798C (en) 2001-02-06
FI973484A0 (fi) 1997-08-25
AU699291B2 (en) 1998-11-26
EP0812206B1 (en) 2002-07-10
ES2179187T3 (es) 2003-01-16
DE69622259T2 (de) 2003-03-27
KR19980702490A (ko) 1998-07-15

Similar Documents

Publication Publication Date Title
DK0724456T3 (da) CD40-Antistoffer
DK0812206T3 (da) Fremgangsmåde til stimulering af en immunrespons
NO963168L (no) Immunstimulatoriske monoklonale antistoffer
DE69221147D1 (de) Nicht glycosylierter Anti-CD3-IgG-Antikörper
DE69316948D1 (de) Lösliche Liganden für CD40
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
ATE213507T1 (de) Methode zur bindung von material an das beta- amyloid-peptid
EP1266965A3 (en) Recombinant antibodies for human therapy
IL221708A0 (en) Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
NO971059L (no) Modifiserte human-C3-proteiner
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
DE60109359D1 (de) Verwendung von anti-ferritin antikörper bei der behandlung von bestimmten krebsarten
ATE309371T1 (de) Protein mit dnase-aktivität
DE69118702D1 (de) Neue verwendung eines monoklonalen antikörpers
NZ314010A (en) A method of targeting intracellular binding proteins using a lipidized antibody